Search By Initial

Name Index C

• CEP-33779 (Catalog# : 73105, Cas# : 1257704-57-6)CEP33779 is a selective JAK2 inhibitor with IC50 of 1.8 nM. CEP33779(< 3 M) inhibi
• CID755673 (Catalog# : 73104, Cas# : 521937-07-5)CID 755673 is a selective and potent protein kinase D1-D3, PKC, CAK, PLK1 and CAMKII
• CGI-1746 (Catalog# : 73103, Cas# : 910232-84-7)CGI1746 is a potent and highly selective small-molecule inhibitor of the Btk with IC5
• CPI-169(racemate) (Catalog# : 72804, Cas# : 1450655-76-1)CPI-169 racemate is the racemate form of CPI-169, which is a novel and potent EZH2 in
• CHZ868(CHZ-868) (Catalog# : 72001, Cas# : 1895895-38-1)CHZ868,a type II JAK inhibitor, would demonstrate activity in JAK inhibitor persisten
• Capivasertib ( AZD5363 ) (Catalog# : 71805, Cas# : 1143532-39-1)Capivasertib is a novel pyrrolopyrimidine derivative, and an orally available inhibit
• CO-1686(Rociletinib) (Catalog# : 60701, Cas# : 1374640-70-6)CO-1686(Rociletinib) is an irreversible inhibitor of epidermal growth factor receptor
• Coluracetam (Catalog# : 52782, Cas# : 135463-81-9)Coluracetam(MKC-231) is a new choline uptake enhancer.
• Chenodeoxycholic Acid (Catalog# : 52781, Cas# : 474-25-9)Chenodeoxycholic Acid (CDCA), is a hydrophobic primary bile acid that activates nucle
• Cerdulatinib (PRT062070, PRT2070) (Catalog# : 52780, Cas# : 1369761-01-2)Cerdulatinib (PRT-062070) is an oral active, multi-targeted tyrosine kinase inhibitor
• Cediranib (Catalog# : 52779, Cas# : 288383-20-0)Cediranib (AZD2171) is a highly potent VEGFR(KDR) inhibitor with IC50 of <1 nM, al
• Cabozantinib S-malate (Catalog# : 52778, Cas# : 1140909-48-3)Cabozantinib S-malate (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0
• Cabozantinib (Catalog# : 52777, Cas# : 849217-68-1)Cabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM a
• CX-5461 (Catalog# : 52748, Cas# : 1138549-36-6)CX-5461 is an inhibitor of rRNA synthesis, selectively inhibits Pol I-driven transcri
• CZC24832 (Catalog# : 52735, Cas# : 1159824-67-5)CZC24832 is a selective inhibitor of PI 3-kinase (IC50 = 1.0 M in a PI 3-K-dependent
• Canagliflozin (Catalog# : 52724, Cas# : 842133-18-0)Canagliflozin(JNJ 28431754; TA 7284) is a highly potent and selective SGLT2 inhibitor
• CAY10603 (Catalog# : 52705, Cas# : 1045792-66-2)CAY10603 is a potent and selective inhibitor of HDAC6 with IC50 of 2 pM, as compared
• CCT128930 (Catalog# : 52635, Cas# : 885499-61-6)CCT128930 is a novel potent ATP-competitive, selective Akt2 inhibitor with an IC50 of
• CDK4-IN-1 (Catalog# : 52610, Cas# : 1256963-02-6)CDK4 inhibitor is a novel and specific CDK4/Cyclin D1 inhibitor with an IC50 of 10 nM
• Carfilzomib (Catalog# : 52608, Cas# : 868540-17-4)Carfilzomib (PR-171) is an irreversible proteasome inhibitor with IC50 of <5 nM.
• CZC-54252 (Catalog# : 52566, Cas# : 1191911-27-9)CZC-54252 is a potent inhibitor of LRRK2 with IC50s of 1.28 nM and 1.85 nM for wild-t
• CK-636 (Catalog# : 52544, Cas# : 442632-72-6)CK-636(CK-0944636) is a small molecule inhibitor of Arp2/3 complex; Inhibitor of acti
• CYT387 (Catalog# : 52534, Cas# : 1056634-68-4)CYT387(momelotinib) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 11 nM/1
• CID 2011756 (Catalog# : 52532, Cas# : 638156-11-3)CID-2011756 is a cell-active ATP competitive and specific PKD1 inhibitor that inhibit
• Clemizole (Catalog# : 52520, Cas# : 476-34-6)Clemizole is a H1 histamine receptor antagonist.Recently, researchers have identified
• CI-994 (Catalog# : 52517, Cas# : 112522-64-2)CI-994 (Tacedinaline) is an anti-cancer drug which inhibits HDAC1 with IC50 of 0.57 M
• Chidamide (Catalog# : 52506, Cas# : 743420-02-2)Chidamide(CS055; HBI-8000) is a class I HDAC inhibitor with IC50s of 95/160/67/733 nM
• CCG-1423 (Catalog# : 52502, Cas# : 285986-88-1)CCG-1423 is a novel inhibitor of RhoA/C-mediated gene transcription that is capable o
• CTX-0294885 (Catalog# : 52213, Cas# : 1439934-41-4)CTX-0294885 is a a novel bisanilino pyrimidine; exhibits inhibitory activity against
• CX-6258 (Catalog# : 52234, Cas# : 1202916-90-2)CX-6258 is a potent, orally efficacious Pim 1/2/3 kinase(IC50=5 nM/25 nM/16 nM) inhib